Lisanti Capital Growth’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-68,155
Closed -$4.81M 159
2022
Q3
$4.81M Sell
68,155
-101,850
-60% -$8.72M 0.64% 63
2022
Q2
$12.1M Buy
170,005
+95,675
+129% +$6.16M 1.64% 18
2022
Q1
$5.94M Buy
+74,330
New +$5.54M 0.67% 62
2021
Q4
Sell
-36,905
Closed -$4.74M 145
2021
Q3
$4.74M Sell
36,905
-26,380
-42% -$3.69M 0.7% 58
2021
Q2
$9.65M Sell
63,285
-20,350
-24% -$2.68M 1.2% 22
2021
Q1
$8.82M Buy
+83,635
New +$8.37M 1.13% 29
2020
Q3
Sell
-104,715
Closed -$6.44M 144
2020
Q2
$6.44M Buy
+104,715
New +$4.28M 1.31% 22
2020
Q1
Sell
-178,785
Closed -$6.29M 145
2019
Q4
$6.29M Buy
+178,785
New +$5.9M 1.67% 11
2019
Q2
Sell
-78,490
Closed -$2.68M 127
2019
Q1
$2.68M Sell
78,490
-41,010
-34% -$1.45M 0.95% 45
2018
Q4
$3.81M Buy
119,500
+27,220
+29% +$1.06M 1.54% 24
2018
Q3
$4.43M Buy
92,280
+33,185
+56% +$1.36M 1.54% 19
2018
Q2
$1.83M Buy
+59,095
New +$1.38M 0.7% 61
2014
Q3
Sell
-122,925
Closed -$2.06M 108
2014
Q2
$2.06M Buy
122,925
+56,450
+85% +$929K 0.92% 54
2014
Q1
$1.25M Buy
+66,475
New +$1.07M 0.54% 78

Other funds holding STAA

Lisanti Capital Growth's STAA Position: Q4 2022 in Review

Lisanti Capital Growth sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 68,155 shares — an estimated $4.81M sold.

Lisanti Capital Growth first reported a position in STAA in Q1 2014 and held it in 14 quarters. The position peaked at $12.1M in Q2 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Lisanti Capital Growth reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Lisanti Capital Growth sold 68,155 STAAR Surgical shares in Q4 2022, an estimated $4.81M.
  • Lisanti Capital Growth first reported a position in STAAR Surgical in Q1 2014 and held it in 14 quarters.
  • Lisanti Capital Growth's STAAR Surgical position peaked at $12.1M in Q2 2022.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Lisanti Capital Growth's 13F filing for Q4 2022, filed 6 Feb 2023.